1
/
of
12
www.ChineseStandard.us -- Field Test Asia Pte. Ltd.
YY/T 0285.6-2020 English PDF (YY/T0285.6-2020)
YY/T 0285.6-2020 English PDF (YY/T0285.6-2020)
Regular price
$305.00
Regular price
Sale price
$305.00
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
YY/T 0285.6-2020: Intravascular catheters - Sterile and single-use catheters - Part 6: Subcutaneous implanted ports
Delivery: 9 seconds. Download (and Email) true-PDF + Invoice.Get Quotation: Click YY/T 0285.6-2020 (Self-service in 1-minute)
Newer / historical versions: YY/T 0285.6-2020
Preview True-PDF
Scope
This Part of YY/T 0285 specifies the relevant performance and safety requirements forsterile and single-use subcutaneous implanted ports. This Part applies to the
subcutaneous implanted ports intended for long-term or persistent intravascular use,
consisting of a subcutaneously implanted infusion port and catheter.
NOTE 1: The known subcutaneous implanted ports are also used for non-endovascular indications
such as intraperitoneal, intrathecal and epidural access. The implanted ports based on risk
assessment and for non-endovascular applications only may refer to this Part. All subcutaneous
implanted ports for non-endovascular applications are encouraged to implement the requirements
of this Part.
This Part does not specify the performance and safety requirements related to the non-
coring needle for the implanted ports (hereinafter referred to as the non-coring needle).
NOTE 2: See YY 0881 for the requirements for the non-coring needle.
Basic Data
| Standard ID | YY/T 0285.6-2020 (YY/T0285.6-2020) |
| Description (Translated English) | Intravascular catheters - Sterile and single-use catheters - Part 6: Subcutaneous implanted ports |
| Sector / Industry | Medical Device and Pharmaceutical Industry Standard (Recommended) |
| Classification of Chinese Standard | C31 |
| Classification of International Standard | 11.040.25 |
| Word Count Estimation | 19,179 |
| Date of Issue | 2020-09-27 |
| Date of Implementation | 2021-09-01 |
| Regulation (derived from) | Announcement No. 108 (2020) of the National Medical Products Administration |
| Issuing agency(ies) | State Drug Administration |
Share
